Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $111.6400 (-0.24%) ($109.5700 - $113.6400) on Sun. Jul. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.48% (three month average) | RSI | 57 | Latest Price | $111.6400(-0.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.74% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.74% (StdDev 3.48%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $113.94 | 5 Day Moving Average | $112.25(-0.54%) | 10 Day Moving Average | $113.18(-1.36%) | 20 Day Moving Average | $113.94(-2.02%) | To recent high | -9.7% | To recent low | 44.2% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |